Takeda Pharmaceuticals International AG
For individuals donating plasma at BioLife centers who require tools for managing appointments and tracking compensation payments.
Snapshot
Who is Takeda Pharmaceuticals International AG?
Streamlining the plasma donation experience for donors through digital scheduling and reward management.
Target audience
Portfolio
Free 4Last updated
BioLife Plasma Services
v3.1.8
8mo ago
Publisher DNA
What defines Takeda Pharmaceuticals International AG?
Publisher DNA
Primary focus
Medical utility for plasma donation
Scale
indie
Target audience
Individuals donating plasma at BioLife centers who require tools for managing appointments and tracking compensation payments.
Signature Patterns
- •Focus on high-utility medical logistics and donor management
- •Monetization via a 100% free-to-user model without ads
- •Integration of financial reward tracking with service scheduling
- •Consistent maintenance cadence to ensure operational reliability
Portfolio momentum
Maintains a high update cadence with 5 releases in the last 6 months for its single active title, with the most recent update occurring 17 days ago.
Portfolio
What does Takeda Pharmaceuticals International AG ship?
Apps
4 apps analysed
Donating plasma just got easier with the BioLife Plasma Services mobile app.
- The core donation scheduling and tracking interface provides a simple and efficient experience for regular donors
- Persistent login failures and verification code errors prevent users from accessing their accounts and scheduling appointments
Analysis in progress
Analysis in progress
Analysis in progress
Single-market publisher, every app ships only to United States.
Based on 1 of 4 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
25/100
Avg sentiment score
Rivals
Who does Takeda Pharmaceuticals International AG compete with?
The rivals identified
Nemeses(1)
Both applications serve the same donor base within the US medical category, competing directly for appointment scheduling and donor management utility.
Contenders(7)
Both applications serve plasma donors within specific pharmaceutical networks, competing for user retention through appointment scheduling and compensation tracking.
Both applications target plasma donors seeking to manage appointments and track compensation, creating direct competition for user retention and donation activity.
Both applications serve the same donor demographic by providing appointment scheduling and reward management for plasma donation centers.
Both applications serve the same donor demographic by providing tools for appointment scheduling, compensation tracking, and loyalty program management within the plasma donation sector.
Both applications serve the same donor demographic by providing appointment scheduling and compensation tracking within the plasma donation industry.
Both apps serve the same donor demographic by providing digital tools for appointment scheduling and compensation management within their respective plasma collection networks.
Both applications serve the same plasma donor demographic by providing appointment scheduling and compensation tracking tools within the medical utility category.
Same space(6)
This app serves as a broad-spectrum donation management tool for the American Red Cross, offering a wider scope of donation types than the plasma-specific BioLife platform.
This platform acts as a directory for plasma matching, contrasting with the BioLife corporate-managed donation model by focusing on direct donor-to-patient connections.
This regional utility targets a similar donor base but operates as a nonprofit, highlighting the gap in automated screening tools present in the BioLife experience.
It occupies the adjacent medical management space by providing a digital interface for lab appointments and health records, overlapping with the clinical nature of plasma donation.
This app provides a localized donor management interface for New Zealand, serving as a geographic alternative for users outside the Takeda network.
It offers a similar appointment scheduling interface for plasma and blood donors, requiring prior online registration to access mobile features.
The Analyst's Read
The bottom line on Takeda Pharmaceuticals International AG
Bottom line
Takeda's mobile strategy is a specialized extension of its physical medical services, successfully digitizing the donor experience to support its plasma supply chain. The high review volume for a single-purpose utility indicates strong product-market fit within its specific donor base.
Frequently asked questions
How many apps does Takeda Pharmaceuticals International AG publish?
What kind of apps does Takeda Pharmaceuticals International AG make?
What is Takeda Pharmaceuticals International AG's top app?
In how many countries are Takeda Pharmaceuticals International AG's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 0
- With overview:
- 1
- Website scraped:
- no
- Social presence:
- yes